DN
Ginkgo Bioworks Holdings, Inc.
DNA · NYSE
$6.96 +0.07% (+$0.01)
1M -9.15%
Market Cap $453.7M
P/E Ratio -
Div. Yield -
ROE 60.21%
Bulios Fair Price
$4.53
34.9% downside
Trenutna cena
$6.96
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DNA trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
72 /100
Cheap P/B 1.08x
P/S 4.06x
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 33.59%
Rev. growth 29.11%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 259.86%
Gross margin 80.09%
FCF margin 169.96%
Quality
1 /100
Poor ROA 29.37%
ROIC 31.63%
Asset turnover 0.11x
Debt
68 /100
Low Current ratio 4.57x
Debt/Equity 0.96x
Debt/Assets N/A
Stability
51 /100
Moderate EPS volatility 10.98%
Beta 1.79x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DNA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jason Kelly
Employees
485
Headquarters
Boston
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report